学术会议:紧随研究趋势 洞察学术热点 进入>
产业会议:新技术,新领域,深入产业环节 进入>
举办会议及论坛超过百场 邀请海内外院士超过50名 教授PI专家授课超过1000名 总参会人数超过10万人
2018-08-24至2018-08-25 上海
导航

已确认嘉宾Confirmed Guests

赵荣华 首席医学官

复诺健生物科技有限公司

赵荣华 首席医学官

复诺健生物科技有限公司

● PhD in Surgery and Bachelor of Clinical Medicine from Second Military Medical University 
● Experience in pre-clinical and clinical development of novel oncolytic viruses H101 and H103,  H101(Oncorine) was approved by CFDA to treat  advanced HNSCC in 2005.
Experience in non-clinical development of small-molecule anti-cancer drug candidate KX02, which gained CFDA IND approval in 2017 
● Declared 3 patents, published 47 papers, and received multiple NIH & domestic research grants 
● In-depth experience of translational medical research and of clinical and non-clinical development of novel anti-cancer drugs; familiar with regulations and guidelines.

邀请函

下载邀请函

赞助企业

×
留下姓名电话和邮箱,邀请函直接发送到邮箱
*姓名:
* 电话:
* Email: